Six more biotechs price public debuts just before the start of the weekend
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
Another six biotechs priced IPOs on Thursday and Friday, joining this week’s big rush to Wall Street. Biotech companies have raised more than $11.7 billion so far this year, closing in on last year’s record $16.5 billion raise.
Scroll down for everything you need to know about the latest companies hitting Nasdaq.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.